glp 1 for substance use disorder GLP-1 and Disorder: Research and Clinical Insights Glucagon-like peptide-1 receptor agonists and

By the studys end, people who stayed on the highest dose lost an average of 28.4% of their baseline weight, amounting to 71 pounds, while those on the lower dose lost an average of 26.4% body weight (the placebo group lost an average of 2.1%)

Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, said in the Oval Office that one in three people who can hear my voice are medically eligible for the class of drugs

When nearly 70% of American adults struggle with obesity or are overweight, managing these conditions is crucial

Car cooling strategies The best approach for road trips is a dedicated small cooler that stays in the front passenger area, not the trunk